Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)
44.29
+0.81 (1.86%)
Mar 9, 2026, 4:00 PM EDT
SHA:688273 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 461.56 | 991.63 | 1,176 | 272.62 |
Trading Asset Securities | - | 433.42 | 105.65 | 40 | - |
Cash & Short-Term Investments | 810.38 | 894.98 | 1,097 | 1,216 | 272.62 |
Cash Growth | -9.45% | -18.44% | -9.75% | 345.98% | 81.97% |
Accounts Receivable | - | 17.79 | 11.41 | 26.84 | 10.18 |
Other Receivables | - | 1.16 | 1.47 | 1.46 | 0.3 |
Receivables | - | 18.94 | 12.88 | 28.3 | 10.48 |
Inventory | - | 73.05 | 55.02 | 68.59 | 38.49 |
Prepaid Expenses | - | 0.16 | - | - | - |
Other Current Assets | - | 14.52 | 6.67 | 7.9 | 19.69 |
Total Current Assets | - | 1,002 | 1,172 | 1,321 | 341.28 |
Property, Plant & Equipment | - | 327.42 | 207.59 | 154.73 | 123.82 |
Long-Term Investments | - | 98.73 | 79.7 | 0.56 | 0.44 |
Goodwill | - | 41.9 | 0.91 | 0.91 | 0.91 |
Other Intangible Assets | - | 55.61 | 31.21 | 18.5 | 7.19 |
Long-Term Deferred Tax Assets | - | 9.49 | 9.99 | 6.14 | 6.47 |
Long-Term Deferred Charges | - | 8.13 | 5.27 | 6.59 | 8.03 |
Other Long-Term Assets | - | 3.69 | 27.4 | 3.88 | 0.59 |
Total Assets | - | 1,547 | 1,534 | 1,512 | 488.74 |
Accounts Payable | - | 17.04 | 9.16 | 12.57 | 13.09 |
Accrued Expenses | - | 37.65 | 23.97 | 26.6 | 32.64 |
Short-Term Debt | - | 7.01 | - | - | - |
Current Portion of Leases | - | 2.94 | 6.13 | 1.44 | 2.12 |
Current Income Taxes Payable | - | 0.68 | 3.45 | 9.26 | 5.12 |
Current Unearned Revenue | - | 51.27 | 45.66 | 47.98 | 33.3 |
Other Current Liabilities | - | 46.38 | 44.86 | 25.7 | 13.85 |
Total Current Liabilities | - | 162.96 | 133.24 | 123.55 | 100.11 |
Long-Term Leases | - | 0.65 | 2.37 | 7.99 | 4.1 |
Long-Term Unearned Revenue | - | 15.94 | 17.75 | 6.03 | 10.44 |
Long-Term Deferred Tax Liabilities | - | 5.46 | 5.25 | 4.39 | 1.36 |
Other Long-Term Liabilities | - | 14.64 | - | - | - |
Total Liabilities | - | 199.66 | 158.6 | 141.96 | 116.01 |
Common Stock | - | 100 | 100.62 | 100 | 75 |
Additional Paid-In Capital | - | 984.54 | 999.45 | 982.7 | 92.55 |
Retained Earnings | - | 279.91 | 276.8 | 267.48 | 195.95 |
Treasury Stock | - | -52.25 | -31.09 | - | - |
Total Common Equity | 1,368 | 1,312 | 1,346 | 1,350 | 363.5 |
Minority Interest | - | 34.76 | 29.54 | 19.77 | 9.24 |
Shareholders' Equity | 1,395 | 1,347 | 1,375 | 1,370 | 372.74 |
Total Liabilities & Equity | - | 1,547 | 1,534 | 1,512 | 488.74 |
Total Debt | 16.43 | 10.6 | 8.51 | 9.43 | 6.22 |
Net Cash (Debt) | 793.95 | 884.38 | 1,089 | 1,206 | 266.4 |
Net Cash Growth | -10.22% | -18.77% | -9.75% | 352.86% | 86.98% |
Net Cash Per Share | 8.12 | 8.98 | 10.89 | 14.48 | 3.55 |
Filing Date Shares Outstanding | 97.78 | 97.81 | 99.51 | 100 | 75 |
Total Common Shares Outstanding | 97.81 | 97.86 | 100.62 | 100 | 75 |
Working Capital | - | 838.7 | 1,039 | 1,197 | 241.17 |
Book Value Per Share | 13.99 | 13.41 | 13.37 | 13.50 | 4.85 |
Tangible Book Value | 1,277 | 1,215 | 1,314 | 1,331 | 355.4 |
Tangible Book Value Per Share | 13.06 | 12.41 | 13.06 | 13.31 | 4.74 |
Buildings | - | 112.1 | 112.1 | 112.1 | 112.1 |
Machinery | - | 53.53 | 44.39 | 37.31 | 21.95 |
Construction In Progress | - | 203 | 77.04 | 19.99 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.